Susan G. Komen Greater Kansas City is proud to continue local representation on the Susan G. Komen Scientific Advisory Board (SAB): Cheryl Jernigan, CPA, FACHE. Jernigan also serves on the Komen Kansas City Board of Directors. Her focus continues to be on patient and research advocacy; clinical trials, clinical data research; big data (BD4BC); and cancer prevention. Jernigan is also a 21-year breast cancer survivor and one of the leading team captains (based on dollars raised) for the local Race for the Cure.
She was previously CEO of the Kansas City Area Hospital Association, and has over 20 years of experience in health policy, advocacy and community/national leadership on behalf of hospitals. She is Chair of the Breast Cancer Prevention Center’s Advocate Advisory Board for The University of Kansas Medical Center and The University of Kansas Hospital, and she is the Lead Advocate of Patient & Investigator Voices Organizing Together (PIVOT), a new University of Kansas Cancer Center initiative. Jernigan is a founding and current board member and Chair of the Strategic Mission Committee of the Greater Kansas City Komen Affiliate, and a member of the Steering Committee of Komen’s Advocates In Science program. An active research advocate, Jernigan is a member of many clinical trial initiatives, including the National Cancer Institute’s Central Institutional Review Board for Adult Late Phase Clinical Trials. Jernigan is also one of the experts involved with Komen’s big data initiative.
In addition to Jernigan, the Greater Kansas City community is fortunate to be the home of Komen Scholar Danny Welch, PHD, Professor and Chair, Adjunct faculty of Department of Molecular & Integrative Physiology. Welch, a researcher at the University of Kansas Medical Center, focuses on laboratory and translational research; metastasis; as well as mitochondrial genetics and mutations that lead to breast cancer. Welch is also a multi-year recipient of Komen Promise Grant dollars for his work on metastasis.
Click here to see a full list of the 2017-2018 Komen Mission Advisors..
Komen’s Mission Advisors
Komen’s Mission Advisors are the best and brightest researchers, clinicians, advocates & other experts who guide/help implement our mission programs.
Thanks to their efforts, we’re driving discovery, affecting change & accelerating progress in the fight against breast cancer.
The Scientific Advisory Board are providing strategic guidance for our research & scientific programs. They play a key role in prioritizing our global research investment. The SAB is led by the chief scientific advisors & acts as the executive committee of the Komen Scholars.
The Komen Scholars (KS) are an international group that has a wide range of expertise (clinical & laboratory research, surgery, pathology, prevention, disparities, radiation oncology & other specialties).
They contribute in many ways to Komen’s mission programs & other activities/events with primary responsibility for leading & reviewing during Komen’s scientific peer review process. KS serve as ambassadors & experts in our communities and across the Affiliate Network.
Several of the KS are Advocates in Science who ensure that the unique perspectives of those affected by breast cancer are fully integrated in our decisions at every step of the research process.